首页 | 本学科首页   官方微博 | 高级检索  
     

复方六月青对肝纤维化大鼠肝脏Ⅰ型胶原合成的抑制作用
引用本文:张士军,陈兆霓,张志伟,刘曦,付书婕,黄仁彬. 复方六月青对肝纤维化大鼠肝脏Ⅰ型胶原合成的抑制作用[J]. 中国实验方剂学杂志, 2010, 16(17): 140-143
作者姓名:张士军  陈兆霓  张志伟  刘曦  付书婕  黄仁彬
作者单位:1. 广西医科大学药理学教研室,南宁,530021
2. 广西中医学院附属瑞康医院,南宁,530011
基金项目:广西科学研究与技术开发计划项目(桂科攻0322024-5E);广西研究生教育创新计划资助项目(2006105981007D14)
摘    要:
目的:研究复方六月青(CLYQ)对四氯化碳(CCl4)致肝纤维化大鼠肝组织Ⅰ型胶原(Col I)合成的抑制作用。方法:SD大鼠sc CCl4建立肝纤维化模型,随机分为5组:模型对照组、秋水仙碱组、CLYQ高剂量组、中剂量组、低剂量组,并设正常SD大鼠为空白对照组。模型组和空白对照组ig生理盐水,其他组ig相应的药物,连续4周。采用实时荧光定量PCR法检测各组肝组织Col I mRNA表达情况,采用免疫组织化学法检测各组肝组织Col I蛋白表达情况。结果:与模型对照组比,CLYQ各剂量组大鼠肝组织Col I mRNA的表达均下调(P0.01),且表现一定的剂量依赖性;CLYQ各剂量组大鼠肝组织Col I蛋白阳性表达面积和强度显著减少和减弱(P0.01或P0.05),且呈明显的剂量依赖性。结论:CLYQ可下调肝纤维化大鼠肝组织Col I mRNA表达及其蛋白质合成以抑制细胞外基质的沉积,从而发挥其抗肝纤维化的作用。

关 键 词:复方六月青  肝纤维化  Ⅰ型胶原  实时荧光定量PCR  免疫组织化学法
收稿时间:2010-05-22

Inhibitory Effect of Compound Liuyueqing on Synthesis of Collagen Type I in Hepatic Tissues in Rats with Hepatic Fibrosis
ZHANG Shi-Jun,CHEN Zhao-ni,ZHANG Zhi-wei,LIU Xi,FU Shu-Jie and HUANG Ren-bin. Inhibitory Effect of Compound Liuyueqing on Synthesis of Collagen Type I in Hepatic Tissues in Rats with Hepatic Fibrosis[J]. China Journal of Experimental Traditional Medical Formulae, 2010, 16(17): 140-143
Authors:ZHANG Shi-Jun  CHEN Zhao-ni  ZHANG Zhi-wei  LIU Xi  FU Shu-Jie  HUANG Ren-bin
Affiliation:Department of Pharmacology, Guangxi Medical University, Nanning 530021, China;Department of Pharmacology, Guangxi Medical University, Nanning 530021, China;Affiliated Ruikang Hospital, Guangxi Traditional Chinese Medicine University, Nanning 530011, China;Department of Pharmacology, Guangxi Medical University, Nanning 530021, China;Department of Pharmacology, Guangxi Medical University, Nanning 530021, China;Department of Pharmacology, Guangxi Medical University, Nanning 530021, China
Abstract:
ObJective: To study the inhibitory effect of Compound Liuyueqing(CLYQ) on the synthesis of Collagen type I (Col I) in hepatic tissues in rats with hepatic fibrosis. Method: Hepatic fibrosis model of SD rats was induced by subcutaneous inJection (sc) of CCl4. Hepatic fibrosis SD rats were divided into 5 groups randomly: model control group, colchicina-group, high dose, middle dose and low dose of CLYQ groups, and normal SD rats were the blank contol group. Model control group and blank contol group were treated with normal saline, and the other groups were treated with corresponding drugs for four consecutive weeks by intragastric administration (ig). The relative quantification of Col I mRNA expression in hepatic tissues was detected by real time fluorescence quantitative PCR, and the quantification of Col I protein expression was detected by immunohistochemistry. Result: Compared with the model group, the various dosage groups of CLYQ could down regulate significantly Col I mRNA expression (P<0.01) and showed a dose-dependent relationship according to the results of real time fluorescence quantitative PCR. The results of immunohistochemistry showed that after treamented with CLYQ the area and the intensity of Col I protein expression in hepatic tissues were reduced and weakened significantly (P<0.05, or P<0.01) compared with that of the model group. Col I protein expression was reduced obviously in a dose=dependent manner. Conclusion: CLYQ can down-regulate the expression of Col I mRNA and protein synthesis in hepatic tissues of hepatic fibrosis rats. The results suggest that CLYQ can reduce the collagen, thus suppressing the deposition of ECM. Hence CLYQ has the marked effect of anti-hepatic fibrosis.
Keywords:Compound Liuyueqing  hepatic fibrosis  collagen type I  real time fluorescence quantitative PCR  immunohistochemistry
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《中国实验方剂学杂志》浏览原始摘要信息
点击此处可从《中国实验方剂学杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号